TNFSF11 and breast carcinoma: In agreement with other reports [27],[28], we found that parental non-osteotropic breast carcinoma-derived ATCC MDA-231 cells express RANK, the receptor for RANKL, but at a lower level than bone metastatic MDA-231 cells (Figure S3A).